NIH-funded research R21 grant

Developing new animal models for a corneal disease that causes blindness

Official title: New animal model for late-onset Fuchs endothelial corneal dystrophy

Funded at University of Oregon · NIH-11015022 · Data updated 2026-11-12

This study is looking at a genetic eye condition called Fuchs' endothelial corneal dystrophy, which can cause blindness, and aims to create animal models to better understand how it works so that new treatments can be developed to help people with this condition.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Oregon
NIH-funded
Lab location1 site (Eugene, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2026
Funding year2025
Award (this year)$186,250
NIH project number5R21EY034967-02
Project IDNIH-11015022 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with late-onset Fuchs' endothelial corneal dystrophy, particularly those with a family history of the condition.

Less likely to help

Patients with early-onset forms of corneal dystrophy or those without a genetic predisposition to FECD may not benefit from this research.

What this research studies

This research focuses on Fuchs' endothelial corneal dystrophy (FECD), a genetic condition that leads to blindness due to the loss of corneal endothelial cells. The project aims to create new animal models that mimic late-onset FECD, which is prevalent in many patients. By understanding the genetic mutations involved, particularly the expansion of (CTG)n repeats in the TCF4 gene, researchers hope to uncover the mechanisms that lead to cell malfunction. This could pave the way for developing new pharmacologic therapies to treat FECD, addressing a significant unmet medical need.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for Fuchs' endothelial corneal dystrophy, potentially reducing the need for corneal transplants.

How similar studies have gone: While there has been significant research on corneal diseases, the development of specific animal models for late-onset FECD is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Oregon
    Eugene, United States
    Active

Researchers

  • Principal investigator: Uehara, Hironori — University of Oregon
  • Study coordinator: Uehara, Hironori

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.